Givaudan SA (OTCMKTS:GVDNY - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $95.70, but opened at $91.61. Givaudan shares last traded at $91.58, with a volume of 2,639 shares trading hands.
Wall Street Analyst Weigh In
Separately, Barclays upgraded shares of Givaudan from a "strong sell" rating to a "hold" rating in a research report on Tuesday, July 8th.
View Our Latest Report on GVDNY
Givaudan Trading Down 4.3%
The company has a debt-to-equity ratio of 0.86, a current ratio of 1.49 and a quick ratio of 0.98. The stock's fifty day moving average is $98.40 and its two-hundred day moving average is $92.32.
Givaudan Company Profile
(
Get Free Report)
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
